The Gray Foundation invests in collaboration seeking diabetes treatments
Published in UChicago Medicine Giving | February 15, 2024
PREDICT is a concentrated effort to fully understand monogenic diabetes, a rare form of diabetes that accounts for less than five percent of all cases in the US. Louis Philipson, MD, PhD, James C. Tyree Professor of Diabetes Research and Care, said, “We realized our own databases only go so far in understanding the full aspect of this unusual form of diabetes. While we’ve identified roughly 1,500 people with known cases of monogenic diabetes, we’re at a crossroads trying to make headway and we need to have many more groups involved.”
“Data for the Common Good,” Philipson said, “will give us the structure that we need to do this work. The potential for international collaboration will multiply our ability to understand how these genes work and identify appropriate treatments.”
